Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
Clinical trial NCT06350838 · COMPLETED
Trial details
- NCT number
- NCT06350838
- Sponsor
- Chengdu CoenBiotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2023-02-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.